Skip to content
Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac)
Department of Family Medicine and Primary Care, Department of Medicine, Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, School of Biomedical Sciences, School of Clinical Medicine, School of Nursing
Go to Link
Archive

Citation

Li, X., Peng, K., Cheng, F. W. T., Lam, D. C. L., Cheung, C. L., Chui, C. S. L., … Wong, I. C. K. (2023, March). Tuberculosis following two-dose SARS-CoV-2 vaccination with messenger RNA vaccine (BNT162b2) and inactivated virus vaccine (CoronaVac). Journal of Infection. Elsevier BV. http://doi.org/10.1016/j.jinf.2022.12.016

Resource Type

ScholarlyArticle
#Coronavirus vaccines #Innate immunity #Tuberculosis

Addition Details

Date:

2023-03-01

Category:

Research

Source URL:

http://dx.doi.org/10.1016/j.jinf.2022.12.016